研究表明,在治疗 PAD 患者时,与股骨通路相比,径向通路与大出血和通路部位并发症的风险显着降低相关。
AngioDynamics的A...查看全文
产业链观察04-04 20:29
#药闻简讯# 美国FDA已经批准了$AngioDynamics(ANGO)$ 用于治疗肺栓塞(PE)的AlphaVac F1885系统,增强了其在PE等关键医疗场景中的实用性。查看全文
一年交易一次2019-01-04 09:48
$盎格鲁力学(ANGO)$
$卡尔梅尔食品(CALM)$
$Lamb Weston控股(LW)$
RPM国际(RPM)
等四只股票盘前要发财报。#今日财报预告#查看全文
用户18509225712018-07-11 12:20
$盎格鲁力学(ANGO)$ 计划于北京时间 2018-07-11 20:00(2018/07/11 08:00 EDT)举行 2018 财年 Q4 财报电话会议。
AngioDynamics, Inc.主要是设计、制造、销售各类医疗外科和诊断设备,设备用于专业医护人员在血管通路、血管周围疾病治疗和肿瘤手术设置方面的应用。公司1988年开始运营。公司...查看全文
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014709 Size: 4 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014377 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014379 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014373 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014375 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014371 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014367 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014369 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014365 Size: 10 KB 网页链接
$盎格鲁力学(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001567619-22-014363 Size: 4 KB 网页链接